Micron Technologies Limited @ InformEx USA 2010, stand 2135
Second, Micron Technologies has invested in what is believed to be the largest micronisation suite under full containment available in the market; this unit will be ready for customers very soon and has the ability to fully contain small scale as well as large scale equipment to micronise potent and highly potent compounds.
Micronisation is the quickest, most reliable, reproducible and cost-effective technique to bring a poorly soluble drug to market and these investments will enhance Micron Technologies" leadership in particle size reduction and material characterisation.
Trending Articles
You may also like
Packaging
Pharmapack: sustainability collaborations essential to mitigate scope 3 supply chain issues
Ahead of this month’s Pharmapack Europe 2024, Dr Kevin Robinson (KSR) spoke with Silvia Forroova (SF), Director of Partnerships and Sustainability at Informa Markets to find out how the event is helping the industry centralise debate and bring together different stakeholders in the supply chain to accelerate sustainable initiatives